NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,066 | +0.9% | 89 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,981 | +306.7% | 89 | +270.8% | 0.00% | +200.0% |
| Q1 2023 | $2,208 | +1.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,177 | -99.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,824,000 | -10.1% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $2,029,000 | -9.8% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,250,000 | +7.2% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,099,000 | +6.9% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,963,000 | -4.3% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,052,000 | -9.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,266,000 | +8.6% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,087,000 | -0.4% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,096,000 | +104700.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | – | 24 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |